Gastroenterology
The microbial communities inhabiting the gut have been shown to change in ways that influence the development of disease through blood metabolites.
A targeted decontamination could be a strategy to control the spreading of carbapenem-resistance plasmids both amoung patients and within patients.
Gut microbes contribute to symptoms associated with neurological conditions. New microbe-inspired therapies could be develop to treat such conditions.
Microbial transplants could be used as a non-invasive and safe strategy to manipulate the gut microbiota, which has been linked to HIV infection.
Common gut fungi called Debaryomyces hansenii can influence the severity of Crohn’s disease and other inflammatory bowel diseases.
The alterations in gut microbial composition could play a role in the gastrointestinal complications associated with Parkinson’s disease.
Intestinal infections ‘train’ the gut microbiota to produce taurine, which promotes the growth of protective gut bacteria.
Different gut metabolites can influence the Cryptosporidium parasite’s growth and invasion of intestinal cells. A new study published in mBio claims.
Immune responses to the gut microbiota can be used as biomarkers of clinical course in IBD or as targets for the treatment or prevention of the condition.
The findings suggest that delivery mode, rather than birth canal exposure, has a strong influence on the composition of the infant microbiota.
